TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Shilpa Medicare Limited ( (IN:SHILPAMED) ) is now available.
Shilpa Medicare Limited announced that the United States Food and Drug Administration (USFDA) conducted an inspection at Unit-2 of its subsidiary, Shilpa Pharma Lifesciences Limited, from March 10-14, 2025. The inspection concluded with zero observations, marking the second consecutive time the facility has achieved this result, reinforcing the company’s strong compliance and operational standards.
More about Shilpa Medicare Limited
Shilpa Medicare Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is known for its commitment to quality and compliance with international standards, serving both domestic and international markets.
YTD Price Performance: -23.04%
Average Trading Volume: 14,770
Current Market Cap: 63.1B INR
For a thorough assessment of SHILPAMED stock, go to TipRanks’ Stock Analysis page.